廊坊倾力推动京津科技成果落地生金

Core Viewpoint - Langfang is leveraging its geographical advantages to transform technological achievements from Beijing and Tianjin into industrialization through a collaborative model of "Beijing-Tianjin R&D, Langfang incubation and transformation" [6][10]. Group 1: Technological Achievements and Collaborations - The Jinowei Innovation Vaccine Production Base in Langfang has completed its first phase and is set to begin mass production of a quadrivalent influenza vaccine [5][6]. - In the first 11 months of this year, Langfang's technical contract transaction volume reached 629.37 billion yuan, a year-on-year increase of 17.09% [6]. - Langfang has established 126 collaborative R&D platforms with universities and research institutes from Beijing and Tianjin, transferring over 370 technological achievements [8][9]. Group 2: Industry Development and Ecosystem - The city is focusing on key industries such as modern commerce, electronic information, new energy, and new materials, actively engaging with top universities and research institutions [7][8]. - Langfang has introduced over 60 enterprises from Beijing and Tianjin in the biopharmaceutical sector, enhancing collaboration in technology research and development [10][12]. - The establishment of a comprehensive technology financial service system aims to address the financing challenges faced by technology-based SMEs, with a loan balance of 484.21 billion yuan, up 30.02% year-on-year [14][15]. Group 3: Policy and Infrastructure Support - Langfang has implemented various policies to facilitate the transfer and transformation of technological achievements, including guidelines for technology transfer and the establishment of pilot bases [8][12]. - The city has built 10 pilot bases for technology maturation, providing essential support for the engineering and reliability verification of laboratory results [8][9]. - A total of 41 new municipal-level R&D platforms have been established this year, covering multiple key areas such as high-end equipment manufacturing and biomedicine [7][8].